Literature DB >> 16865559

Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.

Audrey Tluczek1, Rebecca L Koscik, Peggy Modaff, Darci Pfeil, Michael J Rock, Philip M Farrell, Caroline Lifchez, Mary Ellen Freeman, William Gershan, Christina Zaleski, Bradley Sullivan.   

Abstract

Newborn screening (NBS) protocols for cystic fibrosis (CF) are the first regional population-based programs to incorporate DNA analysis into their procedures. Research about these programs can inform policy and practice regarding how best to counsel families with abnormal NBS results. The grounded theory method guided interviews with 33 families whose infants had abnormal CF NBS results. A dimensional analysis of these interviews provided a theoretical framework describing parents' preferences regarding counseling during their infant's sweat test appointment. This framework describes the contexts and characteristics of the two main dimensions of parents' preferences: factual information and emotional support. Factual information included learning about the probability of a CF diagnosis, CF disease facts, sweat test procedure, and CF genetics. Social support consisted of offering parents a choice about the timing and amount of CF information, showing empathy for their distress, instilling hope, personalizing counseling, and providing hospitality. This framework also explains the consequences of counseling that matched versus mismatched parental preferences in these domains. Counseling that matched parents preferences reduced parents' distress while mismatched counseling tended to increase parents' worry about their infant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865559     DOI: 10.1007/s10897-006-9031-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  24 in total

1.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

2.  Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers.

Authors:  Carlo Castellani; Luigi Picci; Maurizio Scarpa; Maria Cristina Dechecchi; Luisa Zanolla; Baroukh Maurice Assael; Franco Zacchello
Journal:  Am J Med Genet A       Date:  2005-06-01       Impact factor: 2.802

3.  Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.

Authors:  Michael J Rock; Gary Hoffman; Ronald H Laessig; Greg J Kopish; Thomas J Litsheim; Philip M Farrell
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

Review 4.  Cystic fibrosis.

Authors:  P B Davis; M Drumm; M W Konstan
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

5.  Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

Authors:  Andrew T Braun; Philip M Farrell; Claude Ferec; Marie Pierre Audrezet; Anita Laxova; Zhanhai Li; Michael R Kosorok; Marjorie A Rosenberg; William M Gershan
Journal:  J Cyst Fibros       Date:  2005-11-04       Impact factor: 5.482

6.  Patients' perceptions of what makes genetic counselling effective: an interpretative phenomenological analysis.

Authors:  Rhona Macleod; David Craufurd; Katie Booth
Journal:  J Health Psychol       Date:  2002-03

7.  Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism.

Authors:  G Bodegård; K Fyrö; A Larsson
Journal:  Acta Paediatr Scand Suppl       Date:  1983

8.  Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.

Authors:  Audrey Tluczek; Rebecca L Koscik; Philip M Farrell; Michael J Rock
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

9.  Screening programs to identify children at risk for diabetes mellitus: psychological impact on children and parents.

Authors:  S B Johnson
Journal:  J Pediatr Endocrinol Metab       Date:  2001       Impact factor: 1.634

10.  Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing.

Authors:  A Tluczek; E H Mischler; P M Farrell; N Fost; N M Peterson; P Carey; W T Bruns; C McCarthy
Journal:  J Dev Behav Pediatr       Date:  1992-06       Impact factor: 2.225

View more
  10 in total

Review 1.  A systematic review of the effects of disclosing carrier results generated through newborn screening.

Authors:  R Z Hayeems; J P Bytautas; F A Miller
Journal:  J Genet Couns       Date:  2008-10-28       Impact factor: 2.537

2.  Psychosocial consequences of false-positive newborn screens for cystic fibrosis.

Authors:  Audrey Tluczek; Kate Murphy Orland; Laura Cavanagh
Journal:  Qual Health Res       Date:  2010-09-17

3.  A tailored approach to family-centered genetic counseling for cystic fibrosis newborn screening: the Wisconsin model.

Authors:  Audrey Tluczek; Christina Zaleski; Dania Stachiw-Hietpas; Peggy Modaff; Craig R Adamski; Megan R Nelson; Catherine A Reiser; Sumedha Ghate; Kevin D Josephson
Journal:  J Genet Couns       Date:  2010-10-09       Impact factor: 2.537

4.  When the cystic fibrosis label does not fit: a modified uncertainty theory.

Authors:  Audrey Tluczek; Anne Chevalier McKechnie; Patrice A Lynam
Journal:  Qual Health Res       Date:  2010-02

Review 5.  Newborn screening for cystic fibrosis: a lesson in public health disparities.

Authors:  Lainie Friedman Ross
Journal:  J Pediatr       Date:  2008-09       Impact factor: 4.406

6.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

7.  Newborn screening: an appeal for improved parent education.

Authors:  Audrey Tluczek; Kate Murphy Orland; Sara Wolfgram Nick; Roger L Brown
Journal:  J Perinat Neonatal Nurs       Date:  2009 Oct-Dec       Impact factor: 1.638

8.  A qualitative secondary evaluation of statewide follow-up interviews for abnormal newborn screening results for cystic fibrosis and sickle cell hemoglobinopathy.

Authors:  Alison La Pean; Jenelle L Collins; Stephanie A Christopher; Kerry L Eskra; Sara J Roedl; Audrey Tluczek; Michael H Farrell
Journal:  Genet Med       Date:  2012-02       Impact factor: 8.822

9.  A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.

Authors:  Yvonne Bombard; Fiona A Miller; Carolyn J Barg; Sarah J Patton; June C Carroll; Pranesh Chakraborty; Beth K Potter; Karen Tam; Louise Taylor; Elizabeth Kerr; Christine Davies; Jennifer Milburn; Felix Ratjen; Astrid Guttmann; Robin Z Hayeems
Journal:  Genet Med       Date:  2016-09-08       Impact factor: 8.822

Review 10.  Absorbing it all: A meta-ethnography of parents' unfolding experiences of newborn screening.

Authors:  Ashley L White; Felicity Boardman; Abigail McNiven; Louise Locock; Lisa Hinton
Journal:  Soc Sci Med       Date:  2021-09-03       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.